|
Volumn 17, Issue 2, 2002, Pages 115-119
|
Epilepsy, psychosis and clozapine
|
Author keywords
Clozapine; Epilepsy; Psychosis; Schizophrenia; Seizures
|
Indexed keywords
ANTICONVULSIVE AGENT;
BENZODIAZEPINE;
CARBAMAZEPINE;
CHLORPROMAZINE;
CLOBAZAM;
CLOZAPINE;
DIAZEPAM;
DROPERIDOL;
ETIRACETAM;
FELBAMATE;
GABAPENTIN;
GLUTAMIC ACID;
HALOPERIDOL;
LAMOTRIGINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
OXCARBAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
RISPERIDONE;
SERTINDOLE;
SULPIRIDE;
TIAGABINE;
TOPIRAMATE;
VALPROIC ACID;
VIGABATRIN;
ADULT;
AGRANULOCYTOSIS;
ARTICLE;
BEHAVIOR DISORDER;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG METABOLISM;
DRUG POTENTIATION;
EPILEPSY;
FEMALE;
FREQUENCY ANALYSIS;
HUMAN;
HYPONATREMIA;
KORSAKOFF PSYCHOSIS;
LEUKOPENIA;
MALE;
PANCYTOPENIA;
PRIORITY JOURNAL;
PSYCHOSIS;
RESPIRATION DEPRESSION;
RISK ASSESSMENT;
SCHIZOPHRENIA;
SEDATION;
SEIZURE;
SIDE EFFECT;
AGED;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTICONVULSANTS;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
EPILEPSY;
FEMALE;
HUMANS;
MALE;
PSYCHOTIC DISORDERS;
SEIZURES;
TREATMENT OUTCOME;
|
EID: 0035990104
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/hup.375 Document Type: Article |
Times cited : (49)
|
References (23)
|